| Fri, Nov 20, 2009 |
| • |
Biotech Stock Mailbag: FDA Playbook
at TheStreet.com (Fri, Nov 20)
|
| Mon, Nov 16, 2009 |
| • |
BioElectronics Technology More Effective Than Extra Strength Tylenol(R) in Reducing Muscle Soreness in Clinical Study
Marketwire (Mon, Nov 16)
|
| Wed, Nov 11, 2009 |
| • |
Speculators Betting on BioElectronics' Upcoming Study Results
Marketwire (Wed, Nov 11)
|
| • |
BioElectronics to Announce Results of Acetaminophen Comparison Study
Marketwire (Wed, Nov 11)
|
| Mon, Nov 2, 2009 |
| • |
3 Holiday Stocking Stuffers for Big Gains in 2010
at Seeking Alpha (Mon, Nov 2)
|
| Tue, Oct 20, 2009 |
| • |
BioElectronics Announces Financial Audit
Marketwire (Tue, Oct 20)
|
| • |
BioElectronics: ActiPatch vs. Extra Strength Tylenol Shows Encouraging Results
at Seeking Alpha (Tue, Oct 20)
|
| Mon, Oct 19, 2009 |
| • |
BioElectronics Announces Results From Pilot Section of Acetaminophen Comparative Study
Marketwire (Mon, Oct 19)
|
| Fri, Oct 2, 2009 |
| • |
Biotech Mailbag: Cel-Sci, BioElectronics
at TheStreet.com (Fri, Oct 2)
|
| Wed, Sep 30, 2009 |
| • |
BioElectronics Introduces New Product for $10 Billion Dollar Veterinary Care Market
Marketwire (Wed, Sep 30)
|
| Tue, Sep 29, 2009 |
| • |
BioElectronics Achieves Pink Sheets Current Information Tier
Marketwire (Tue, Sep 29)
|
| Mon, Sep 14, 2009 |
| • |
BioElectronics Wins Wall Street Journal 2009 Innovation Award
Marketwire (Mon, Sep 14)
|
| Wed, Sep 9, 2009 |
| • |
Planned filings have company focused on reaching relevant U.S. pain market
BayStreet Newswire (Wed, Sep 9)
|
| Tue, Sep 8, 2009 |
| • |
A New Audio Interview with Andrew Whelan, CEO of BioElectronics, Inc., is now at SmallCapVoice.com
Business Wire (Tue, Sep 8)
|
| • |
BioElectronics Announces FDA 510(K) Filing Schedule
Marketwire (Tue, Sep 8)
|
| Fri, Sep 4, 2009 |
| • |
Bioelectronics Corporation (OTC:BIEL) ready to launch several new FDA applications
BayStreet Newswire (Fri, Sep 4)
|
| Wed, Aug 26, 2009 |
| • |
Traders angered after brokerage service stalls trading of two OTC stocks (PINK:ASFX), (OTC:BIEL)
BayStreet Newswire (Wed, Aug 26)
|
| • |
BioElectronics Announces Completion of Clinical Study -- Preparing FDA 510(K) Pre-Marketing Notification for OTC Clearance
Marketwire (Wed, Aug 26)
|
| • |
BioElectronics Board Comments on Recent Trading Activity
Marketwire (Wed, Aug 26)
|
| Mon, Aug 24, 2009 |
| • |
BioElectronics Announces Tylenol(R) Comparative Study
Marketwire (Mon, Aug 24)
|
| Older Headlines |
|
|
|
|
Help
0.0005 (0.74%) 
Headlines
